Company intelligence / Profile preview

Agati Capital

Western Australia, Australia

Ownership: Private
Development stage: Other

Overview

Agati Capital is an active Australian family office investment firm, noted for at least one significant investment in a biotechnology company (Aravax, 2024). It is not a drug developer and does not report clinical results.

Industry: Investors

Partnerships

Participates as an investor in syndicates alongside venture funds such as Brandon Capital, Tenmile, Novartis Venture Fund, Uniseed, Unisuper, and Breakthrough Victoria (on Aravax Series B)

Beyond the preview

Go deeper on Agati Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agati Capital.

Explore the full profile